Search Results

There are 3719 results for: content related to: A comparative study of neuroprotective effect of single and combined blockade of AT 1 receptor and PARP -1 in focal cerebral ischaemia in rat

  1. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST)

    International Journal of Stroke

    Volume 10, Issue 6, August 2015, Pages: 830–835, Astrid G. Hornslien, Else C. Sandset, Jannicke Igland, Andreas Terént, Gudrun Boysen, Philip M. W. Bath, Gordon D. Murray and Eivind Berge

    Version of Record online : 22 MAR 2015, DOI: 10.1111/ijs.12477

  2. Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis

    International Journal of Stroke

    Volume 10, Issue 3, April 2015, Pages: 354–359, Mirza Jusufovic, Else Charlotte Sandset, Philip M. W. Bath, Björn W. Karlson, Eivind Berge and on behalf of the Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group

    Version of Record online : 3 DEC 2014, DOI: 10.1111/ijs.12418


    Clinical and Experimental Pharmacology and Physiology

    Volume 32, Issue 9, September 2005, Pages: 714–720, Siriphun Hiranyachattada, Siriwan Saetew and Peter J Harris

    Version of Record online : 20 SEP 2005, DOI: 10.1111/j.1440-1681.2005.04253.x

  4. Angiotensin receptor blockers for heart failure

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Vijaya M Musini, Ken Bassett, Rod S Taylor and James M Wright

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD003040.pub2

  5. You have free access to this content
    European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage

    International Journal of Stroke

    Volume 9, Issue 7, October 2014, Pages: 840–855, Thorsten Steiner, Rustam Al-Shahi Salman, Ronnie Beer, Hanne Christensen, Charlotte Cordonnier, Laszlo Csiba, Michael Forsting, Sagi Harnof, Catharina J. M. Klijn, Derk Krieger, A. David Mendelow, Carlos Molina, Joan Montaner, Karsten Overgaard, Jesper Petersson, Risto O. Roine, Erich Schmutzhard, Karsten Schwerdtfeger, Christian Stapf, Turgut Tatlisumak, Brenda M. Thomas, Danilo Toni, Andreas Unterberg and Markus Wagner

    Version of Record online : 24 AUG 2014, DOI: 10.1111/ijs.12309

  6. You have free access to this content
    Role of NF-κβ and Oxidative Pathways in Atherosclerosis: Cross-Talk Between Dyslipidemia and Candesartan

    Cardiovascular Therapeutics

    Volume 31, Issue 6, December 2013, Pages: 381–387, Najah R. Hadi, Nasser Ghaly Yousif, Mohammed S. Abdulzahra, Bassim I. Mohammad, Fadhil G. al-amran, Murooge L. Majeed and Maitham G. Yousif

    Version of Record online : 27 NOV 2013, DOI: 10.1111/1755-5922.12033

  7. Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer

    Human Cell

    Volume 20, Issue 1, February 2007, Pages: 1–9, Michio KOSUGI, Akira MIYAJIMA, Eiji KIKUCHI, Takeo KOSAKA, Yutaka HORIGUCHI and Masaru MURAI

    Version of Record online : 14 MAY 2007, DOI: 10.1111/j.1749-0774.2007.00025.x

  8. You have free access to this content
    Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis

    British Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 1999, Pages: 645–651, Marc Pfister, Franziska Schaedeli, Felix J. Frey and Dominik E. Uehlinger

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00939.x

  9. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients

    Journal of Clinical Pharmacy and Therapeutics

    Volume 34, Issue 6, December 2009, Pages: 683–692, M. Miura, S. Satoh, H. Kagaya, M. Saito, T. Inoue, T. Ohkubo, T. Habuchi and T. Suzuki

    Version of Record online : 1 JUL 2009, DOI: 10.1111/j.1365-2710.2009.01053.x

  10. You have free access to this content
    Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man

    British Journal of Clinical Pharmacology

    Volume 45, Issue 6, June 1998, Pages: 567–573, Claudius Malerczyk, Bettina Fuchs, Gustav G. Belz, Susanna Roll, Raunhild Butzer, Kerstin Breithaupt-Grögler, Volker Herrmann, Steffen G. Magin, Anette Högemann, Barbara Voith and Ernst Mutschler

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00722.x

  11. You have free access to this content
    Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The CLAIM Study

    The Journal of Clinical Hypertension

    Volume 3, Issue 1, January/February 2001, Pages: 16–21, George Bakris, 1 Alan Gradman, 2 Max Reif, 3 Marian Wofford, 4 Mark Munger, 5 Susan Harris, 6 Jennifer Vendetti, 6 Eric L. Michelson and 6 Rebecca Wang 6

    Version of Record online : 31 MAY 2007, DOI: 10.1111/j.1524-6175.2001.00826.x

  12. You have free access to this content
    Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 57, Issue 6, June 2004, Pages: 807–812, Shuichi Tsuruoka, Michi Wakaumi, Kenta Nishiki, Nobutaka Araki, Kenichi Harada, Koichi Sugimoto and Akio Fujimura

    Version of Record online : 21 APR 2004, DOI: 10.1111/j.1365-2125.2003.02063.x

  13. You have free access to this content
    Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder

    International Journal of Urology

    Volume 19, Issue 5, May 2012, Pages: 457–464, Ken Aikawa, Takio Sakai, Kei Ishibashi, Homare Shiomi, Koji Sagawa, Shin Kumagai, Masao Kataoka, Hidenori Akaihata and Osamu Yamaguchi

    Version of Record online : 9 FEB 2012, DOI: 10.1111/j.1442-2042.2012.02965.x

  14. You have free access to this content
    AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR

    British Journal of Pharmacology

    Volume 142, Issue 5, July 2004, Pages: 821–830, Xiao C Li and Robert E Widdop

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705838

  15. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Michelle MY Wong, Inderjit K Heran and James M Wright

    Published Online : 8 OCT 2008, DOI: 10.1002/14651858.CD003822.pub2

  16. Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation

    European Journal of Clinical Investigation

    Volume 41, Issue 6, June 2011, Pages: 652–658, Maria G. Pavlatou, George Mastorakos, Alexandra Margeli, Evangelia Kouskouni, Nicholas Tentolouris, Nikos Katsilambros, George P. Chrousos and Ioannis Papassotiriou

    Version of Record online : 22 DEC 2010, DOI: 10.1111/j.1365-2362.2010.02453.x

  17. You have free access to this content
    ACE Inhibitor Intolerance and Lessons Learned From the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Trials

    Congestive Heart Failure

    Volume 10, Issue 3, May/June 2004, Pages: 160–164, Domenic A. Sica

    Version of Record online : 23 FEB 2007, DOI: 10.1111/j.1527-5299.2004.02806.x

  18. You have free access to this content
    Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats

    British Journal of Pharmacology

    Volume 159, Issue 3, February 2010, Pages: 709–716, S Bosnyak, IK Welungoda, A Hallberg, M Alterman, RE Widdop and ES Jones

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1476-5381.2009.00575.x

  19. You have free access to this content
    Treatment of Human Mesenchymal Stem Cells with Angiotensin Receptor Blocker Improved Efficiency of Cardiomyogenic Transdifferentiation and Improved Cardiac Function via Angiogenesis


    Volume 29, Issue 9, September 2011, Pages: 1405–1414, Yohei Numasawa, Takehiro Kimura, Shunichiro Miyoshi, Nobuhiro Nishiyama, Naoko Hida, Hiroko Tsuji, Hikaru Tsuruta, Kaoru Segawa, Satoshi Ogawa and Akihiro Umezawa

    Version of Record online : 19 AUG 2011, DOI: 10.1002/stem.691

  20. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring

    International Journal of Clinical Practice

    Volume 60, Issue 4, April 2006, Pages: 391–398, J-P Baguet, 1 S. Nisse-Durgeat, 2 S. Mouret, 1 R. Asmar and 3 J-M Mallion 1

    Version of Record online : 20 MAR 2006, DOI: 10.1111/j.1368-5031.2006.00903.x